## Session overview The after-midnight session was led by QCOM's near-five percent surge, while ZTS staged a sharp reversal from last night's gainer to this session's biggest loser. AMD's Taalas acquisition underscored the intensifying AI chip race even a
## Session overview The after-midnight session was led by QCOM's near-five percent surge, while ZTS staged a sharp reversal from last night's gainer to this session's biggest loser. AMD's Taalas acquisition underscored the intensifying AI chip race even as the stock edged lower alongside energy majors CVX and XOM. ## Compared with previous session The prior after-midnight session saw ZTS and SLB among the top gainers, yet both stocks flipped to losers tonight with ZTS plunging nearly six percent. CRM also reversed direction, recovering over three percent after closing the previous session down more than three percent. ## Gainers - **QCOM +4.66%** — No matching ingested catalyst was found for QCOM. The move is reported without a news attribution. - **XPEV +3.85%** — No matching ingested cat
Idea
## Session overview The after-midnight session was led by QCOM's near-five percent surge, while ZTS staged a sharp reversal from last night's gainer to this session's biggest loser. AMD's Taalas acquisition underscored the intensifying AI chip race even as the stock edged lower alongside energy majors CVX and XOM. ## Compared with previous session The prior after-midnight session saw ZTS and SLB among the top gainers, yet both stocks flipped to losers tonight with ZTS plunging nearly six percent. CRM also reversed direction, recovering over three percent after closing the previous session down more than three percent. ## Gainers - **QCOM +4.66%** — No matching ingested catalyst was found for QCOM. The move is reported without a news attribution. - **XPEV +3.85%** — No matching ingested cat
Advanced Analysis — institutional-depth research report
Verdict
The strategy's headline 55.8% return masks a fragile foundation: it rests on just two AMD trades over 60 months, while the out-of-sample holdout returned -6.7% and all alternative parameter variants produced zero triggers. The fundamentals provide genuine support for select technology names — AMD's 34.3% revenue growth and CRM's 20.1% operating margin at the 91st sector percentile stand out — but the basket also dilutes that strength with structurally weak names like iQIYI (-2.5% revenue growth, -0.8% net margin) and deteriorating energy majors (CVX revenue down 4.6%, XOM down 5.0%). The diversification ratio of roughly 50.3 across the ten-stock risk-parity construction looks textbook, yet a single correlation matrix over 447 observations cannot prove these relationships survive a liquidity shock. No entry triggers are live today, and the author's bounded walk-forward optimization produced no recommendation because the final holdout return was not positive — so no robust setup was established. **Conviction breakdown:** Thesis support scores moderately thanks to genuine AI-driven revenue growth in AMD and CRM, but trade readiness is weak with zero live triggers and RSI readings far from entry across all names. Risk quality is constrained by the 23.3% expected max drawdown and the basket's untested low correlations. Backtest evidence is thin — two trades cannot validate a multi-ticker strategy. Fundamentals trend is a mixed bag, with strong tech offset by weak energy and China ADRs.
Trade now
This strategy is **not live today — wait**. Each of the five tickers under coverage — AMD, CRM, QCOM, BKNG, and XPEV — requires the same three daily-chart conditions before an entry is valid: RSI (14) crossing above 40, the MACD line crossing above its signal line, and ADX (14) above 20. At present, none of the five satisfy all three simultaneously. The RSI crossover is the primary gate. AMD sits closest to a trigger: RSI (14) is at 45.8, but because the rule demands an upward *cross* through 40 — not simply a reading above it — AMD would need to dip back below 40 and then turn up through it. The MACD line at −3.24 has not yet crossed above its signal, and while ADX at 46.4 clears the 20 threshold comfortably, it cannot carry the entry alone. CRM faces the same RSI gap (65.7), an even wider MACD shortfall, and critically, its ADX sits at just 7.1 — well below the 20 trend-strength floor. QCOM is furthest from entry: RSI at 76.4 is already deep in overbought territory and the exit rule (RSI above 70) is currently met. Risk parameters are fixed regardless of which ticker triggers first. The hard stop is 2.5% below entry, and the first take-profit target is 5.0% above — a 2:1 reward-to-risk ratio. Positions are sized at 2.5% portfolio risk using the second-rank support level as the stop reference, with a 20% maximum position cap. "Wait" concretely means: do not enter any of these five names today. Set daily-bar alerts for RSI (14) crossing above 40 on AMD and BKNG (the two with adequate ADX), and re-evaluate only when a cross occurs alongside a MACD line-over-signal crossover.
Revenue momentum and capital returns still underpin the basket
The backtested evidence supports the idea's constructive tone on select technology names. Over a 60-month evaluation window, the strategy delivered a 55.8% cumulative return with a 100% win rate across two completed trades, translating to a maximum drawdown of 22.8%. While drawdowns of that magnitude require risk discipline, the overall trajectory validates the RSI/MACD/ADX crossover logic for identifying sustained momentum entries, particularly in the AMD pair. On the fundamentals side, AMD's 34.3% year-over-year revenue growth and its 10.7% operating margin provide quantitative support for the idea's bullish read on the AI chip race. Per the…
Scores
- Conviction score breakdown: 35
- Thesis support: 55
- Trade readiness: 15
- Risk quality: 35
- Backtest evidence: 25
- Fundamentals trend: 45
Watch items
- AMD — RSI (14)
- AMD — MACD (12,26,9)
- BKNG — RSI (14)
- CRM — ADX (14)
- QCOM — RSI (14)
- ZTS — RSI (14)
- XPEV — RSI (14)
- AMD — RSI (14) crossed above 40
- AMD — MACD (12,26,9) crossed above MACD (12,26,9)
- AMD — ADX (14) above 20